TORONTO, April 15, 2013 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, sluggish economic growth has hindered the large-joint reconstructive implant market in the United States and Europe. Many patients are either uninsured or lack the job security to take time off from work to undergo major surgery, and so postpone knee or hip replacement procedures. Additionally, hospital budget constraints and the growing influence of group purchasing organizations (GPOs) are placing downward pressure on pricing. As a result, the aging population will be the main factor fueling modest growth through 2021, when the US and European markets will reach approximately $8.2 and $2.7 billion in revenue, respectively.
While these overall market trends apply to both the US and Europe, there are differences between these regions. For example, surgeons in the US have become particularly skeptical of partial procedures, such as unicondylar knee replacements or partial hip reconstructions, because of concerns surrounding high revision rates. In Europe physicians continue to use partial procedures more widely due to their lower cost. This is particularly true in countries more affected by uncertain economic conditions, such as Italy.
"Hip resurfacing trends also differ between the United States and Europe," said MRG Analyst Daniel Brown. "These procedures initially experienced high adoption in the US due to their bone preserving nature. However, their popularity has dropped off due to reports of problems with metal-on-metal (MOM) bearing surfaces, used for all of these products. In Europe, this drop is less significant because these procedures never gained the same initial traction that they did in the US, likely due to fewer competitors promoting these products."
Both the US and European markets are dominated by the same five multinational competitors: Zimmer, DePuy Synthes, Stryker, Biomet and Smith & Nephew.
Free Webinar: How the US and Europe Compare in Adopting New Large-Joint Reconstructive Technologies and Surgical Approaches
MRG Analyst Dan Brown analyzes significant ways in which these two large markets differ in terms of adoption of new devices.
April 16, 2013
11 a.m. U.S. Eastern Time
Millennium Research Group's US Markets for Large-Joint Reconstructive Implants 2013 and European Markets for Large-Joint Reconstructive Implants 2013 reports include unit, procedure, average selling price and revenue information, along with market drivers and limiters and a competitive landscape for reconstructive knee and hip implants in the United States, France, Germany, Italy and the United Kingdom. Supplemental country coverage is also available for Austria, Belgium, the Czech Republic, Denmark, Finland, Greece, Hungary, the Netherlands, Norway, Poland, Portugal, Romania, Spain, Sweden, Switzerland and the Ukraine.
About Millennium Research Group
Millennium Research Group (www.MRG.net), a Decision Resources Group company (www.DecisionResourcesGroup.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the healthcare sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack™ projects, customer loyalty tracking, facility-level procedure forecasting, and customized solutions.
About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.
All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.
SOURCE Millennium Research Group